Mr. Cohen leads case teams in support of both public and private attorneys and expert witnesses in complex business litigation.
He has extensive experience in finance matters that include landmark decisions on economic substance, structured finance and transfer pricing, including Long-Term Capital Management, GlaxoSmithKline, Eaton, Altria, BB&T, Fifth Third, Pritired, Buyuk, ITS, and Bank of New York. He has also been involved in several high-profile public health investigations for the federal government involving housing conditions, lead violations, and EPA emissions requirements.
He specializes in valuation, damages and financial analysis across a wide range of industries, including financial services, pharmaceuticals, and manufacturing. He is a Chartered Financial Analyst (CFA) with two decades of experience in both standard valuation of corporations and assets, and complex valuation of subsidiaries and financial instruments. He has provided testimony in US District Court and the Court of Federal Claims, and has been retained by taxpayers and corporations to provide testimony on valuation, economic substance and damages. He was deposed after providing expert reports in a federal case involving valuation and shareholder damages arising from the $22 billion LBO by the Archstone-Smith REIT.
Prior to joining The Brattle Group, Mr. Cohen worked as an investment banking analyst in corporate finance at Dillon, Read & Co. and UBS specializing in debt offerings and mergers and acquisitions in housing, construction and building products. He currently has an active interest in disputes affecting the supply chain for food.